Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) study

British Journal of Clinical Pharmacology

Volumn 63, Issue 4, 2007, Pages 431-437

  Sim, Kang ^a   Lee, N B ^a   Chua, Hong C ^a   Mahendran, Rathi ^a   Fujii, Senta ^b   Yang, Shu Yu ^c   Chong, Mian Yoon ^c   Si, Tianmei ^d   He, Yan L ^e   Lee, Min S ^f   Sung, Kil M ^g   Chung, Eun K ^h   Chan, Yiong H ⁱ   Shinfuku, Naotaka ^b   Tan, Chay H ⁱ   Sartorius, Norman ^j   Baldessarini, Ross J ^k,l  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b KOBE UNIVERSITY   (Japan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e SHANGHAI MENTAL HEALTH CENTER   (China)

^f Korea University College of Medicine   (South Korea)

^g Yonsei University   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j UNIVERSITY OF GENEVA   (Switzerland)

^k HARVARD MEDICAL SCHOOL   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Antidepressant; Diagnosis; East Asia; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; ASIA; CHINA; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DRUG CLASSIFICATION; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; JAPAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL HOSPITAL; MOOD DISORDER; MULTIVARIATE ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; RISK ASSESSMENT; SEX; SINGAPORE; TAIWAN; UNIVARIATE ANALYSIS;

ADULT; ANTIDEPRESSIVE AGENTS; ASIA; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PRESCRIPTIONS, DRUG; RESIDENCE CHARACTERISTICS; SEROTONIN UPTAKE INHIBITORS;

EID: 33947254001     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02780.x     Document Type: Article

References (28)

1. Ciuna A, Andretta M, Corbari L. Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur J Clin Pharmacol 2004; 60: 629-34.
2. McManus P, Mant A, Mitchell P. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. Aust NZ J Psychiatry 2004; 38: 450-4.
3. Lawrenson RA, Tyrer F, Newson RB. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 2000; 59: 149-57.
4. Percudani M, Barbui C, Fortino I. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 2004; 83: 169-75.
5. Barbui C, Broglio E, Laia AC. Cross-sectional database analysis of antidepressant prescribing in Italy. J Clin Psychopharmacol 2003; 23: 31-4.
6. Blazer DG, Hybels CF, Simonsick EM. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000; 157: 1089-94.
7. Hansen DG, Sondergaard J, Vach W. Antidepressant drug use in general practice: inter-practice variation and association with practice characteristics. Eur J Clin Pharmacol 2003; 59: 143-9.
8. Hamed A, Lee A, Ren XS. Use of antidepressant medications: are there differences in psychiatric visits among patient treatments in the Veterans Administration? Med Care 2004; 42: 551-9.
9. De Las Cuevas C, Sanz EJ, De La Fuente JA. Variations in antidepressant prescribing practice: clinical need or market influences? Pharmacoepidemiol Drug Saf 2002; 11: 515-22.
10. Bouhassira M, Allicar MP, Blachier C. Which patients receive antidepressants? A 'real world' telephone study. J Affect Disord 1998; 49: 19-26.
11. Simon GE, Fleck M, Lucas R. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004; 161: 1626-34.
12. Pietraru C, Barbui C, Poggio L. Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. Eur J Clin Pharmacol 2001; 57: 605-9.
13. van Eijk ME, Avorn J, Porsius AJ. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322: 654-7.
14. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58: 19-36.
15. Mamdani MM, Parikh SV, Austin PC. Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry 2000; 157: 360-7.
16. Murray ML, de Vries CS, Wong IC. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004; 89: 1098-102.
17. Depont F, Rambelomanana S, Le Puil S. Antidepressants: psychiatrists' opinions and clinical practice. Acta Psychiatr Scand 2003; 108: 24-31.
18. Baldessarini RJ. Drug therapy of depression and anxiety disorders. Chapter 17. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn, eds Brunton LL, Lazo JS, Parker KL. New York: McGraw-Hill 2005: 429-59.
19. MacGillivray S, Arroll B, Hatcher S. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 2003; 326: 1014.
20. Olfson M, Marcus SC, Druss B. National trends in the outpatient treatment of depression. JAMA 2002; 287: 203-9.
21. Hansen DG, Sondergaard J, Vach W. Socio-economic inequalities in first-time use of antidepressants: a population-based study. Eur J Clin Pharmacol 2004; 60: 51-5.
22. Olfson M, Marcus SC, Pincus HA. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998; 55: 310-6.
23. Zito JM, Safer DJ. Recent child pharmacoepidemiological findings. J Child Adolesc Psychopharmacol 2005; 15: 5-9.
24. Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 2002; 36: 1375-9.
25. Glassman A, Shapiro PA, Ford DE. Cardiovascular health and depression. J Psychiatr Pract 2003; 9: 409-21.
26. Jiang W, Davison JR. Antidepressant therapy in patients with ischemic heart disease. Am Heart J 2005; 151: 871-81.
27. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 57-65.
28. Zimmerman M, Posternak M, Friedman M. Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 2004; 161: 1285-9.